 |
| LST |
14 |
07/01/2003
|
Gen.
References for Guidance as of July 1, 2003 |
|
|
|
pdf |
| C |
30 |
05/07/2003
|
National
Grain & Feed Assn |
Randall
C. Gordon |
|
|
pdf |
| C |
29 |
05/07/2003
|
Medrad |
William
R. Fisher |
|
|
pdf |
| C |
28 |
05/01/2003
|
Bectin,
Dickinson & Company (BD) |
Patricia
B. Shrader, Esq. |
|
|
pdf |
| C |
27 |
04/30/2003
|
National
Food Processors Assn (NFPA) |
Sia
Economides & Allen Matthys |
|
|
pdf |
| C |
26 |
04/28/2003
|
SEC
Associates, Inc. (SEC) |
John
C. McKenney, Sr. |
|
|
pdf
1, pdf 2 |
| C |
25 |
04/28/2003
|
Purdue
Pharma L.P. |
Albert
W. Stockalis |
|
|
pdf
1, pdf 2 |
| C |
24 |
04/28/2003
|
Dow
Chemical Company |
Mark
Duvall |
|
|
pdf
1, pdf 2 |
| C |
23 |
04/28/2003
|
Aventis
Pharmaceuticals, Inc. |
Steve
Caffe, M.D. |
|
|
pdf |
| C |
22 |
04/28/2003
|
National
Electrical Manufacturers Assn |
Robert
G. Britain & Stephen A. Vastag |
|
|
pdf |
| C |
21 |
04/29/2003
|
Wyeth
Pharmaceuticals |
Roy
J. Baranello, Jr. |
|
|
pdf
1, pdf 2 |
| C |
20 |
04/25/2003
|
CTFA |
E.
Edward Kavanaugh |
|
|
pdf |
| C |
19 |
04/28/2003
|
Industry
Coalition |
Alan
Goldhammer, PhD |
|
|
pdf |
| C |
18 |
04/28/2003
|
PhRMA |
Alan
Goldhammer, PhD |
|
|
pdf |
| C |
17 |
04/25/2003
|
American
Red Cross |
Kathryn J. Waldman |
|
|
pdf |
| C |
16 |
04/24/2003
|
Experimental
Pathology Laboratories, Inc |
Jerry Hardisty, DVM, DACVP
|
|
|
pdf |
| C |
15 |
04/14/2003
|
Scantox |
Eligible |
|
|
pdf |
| C |
14 |
04/23/2003
|
AdvaMed |
Bernie
Liebler |
|
|
pdf |
| C |
13 |
04/22/2003
|
Bristol-Myers
Squibb |
Daniel
E Kli.ngler,PhD |
|
|
pdf |
| C |
12 |
04/21/2003
|
Merck
& Co., Inc. |
David
W. Blois, PhD |
|
|
pdf |
| C |
11 |
04/07/2003
|
Genzyme
Corporation |
Robert
E. Yocher & Juliette E. Shih |
|
|
pdf |
| C |
10 |
03/27/2003
|
Cyberonices,
Inc. |
Cyberonices,
Inc. |
|
|
pdf |
| NWL |
1 |
|
FDA
(2/20/03) |
|
|
|
pdf |
| GDL |
2 |
02/20/2003
|
02/20/2003
|
|
|
|
pdf |
| LST |
13 |
02/07/2003
|
Gen.
References for Guidance 02/07/03 |
|
|
|
pdf
|
Top | Up
| Next
Page last updated:
April 26, 2004
|
|
